Atlas Trials

To Evaluate the Effect of Nesinaact on Non-alcoholic Steatohepatitis Through MRI and Liver Fibroscan in Patients With Type 2 Diabetes

Clinical trial NCT03950505 · UNKNOWN

Trial details

NCT number
NCT03950505
Sponsor
Yonsei University
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Non-alcoholic SteatohepatitisType2 Diabetes
Start date
2020-05-29
Primary completion
2020-12-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.